ArticleCancer medicine2021

Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer.

Yunfei Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.